Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer
ClinicalTrials.gov study NCT01662869. IPD Sharing: Not stated. Countries: 24. Publications: 1.
Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC Patients
ClinicalTrials.gov study NCT02175446. IPD Sharing: NO. Countries: 1. Publications: 24.
De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade
ClinicalTrials.gov study NCT04675827. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Disitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal Cancer
ClinicalTrials.gov study NCT05493683. IPD Sharing: NO. Countries: 1. Publications: 18.
Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer
ClinicalTrials.gov study NCT05705401. IPD Sharing: NO. Countries: 2. Publications: 1.
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)
ClinicalTrials.gov study NCT04784715. IPD Sharing: YES. Countries: 27. Publications: 1.
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
ClinicalTrials.gov study NCT03500991. IPD Sharing: NO. Countries: 1. Publications: 2.
Adapted Physical Activity for Breast Cancer HER2 Positive Patient
ClinicalTrials.gov study NCT02963363. IPD Sharing: Not stated. Countries: 1. Publications: 1.
T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System
ClinicalTrials.gov study NCT02662348. IPD Sharing: YES. Countries: 1. Publications: 26.
Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer
ClinicalTrials.gov study NCT05889390. IPD Sharing: NO. Countries: 1. Publications: 4.
Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or
ClinicalTrials.gov study NCT03065387. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma
ClinicalTrials.gov study NCT03409848. IPD Sharing: NO. Countries: 1. Publications: 2.
Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease
ClinicalTrials.gov study NCT06253650. IPD Sharing: NO. Countries: 1. Publications: 1.
Pyrotinib in Combination With Letrozole in Patients With HER2-Positive, ER-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT04407988. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer
ClinicalTrials.gov study NCT01973660. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT01431196. IPD Sharing: YES. Countries: 1. Publications: 1.
Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
ClinicalTrials.gov study NCT00004067. IPD Sharing: Not stated. Countries: 2. Publications: 21.
Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer
ClinicalTrials.gov study NCT02901301. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer
ClinicalTrials.gov study NCT01827163. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors
ClinicalTrials.gov study NCT04934514. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.